Repligen Corp (RGEN) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $170.32 +1.62%
EPS Growth %: 0.0%
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q2 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $8.63 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
